HOT
Disease site: Breast Cancer
Treatment Modality: Other
Status: In active follow-up
The primary aim is to test the efficacy of hyperbaric oxygen (HBO) therapy in reducing arm lymphoedema in patients suffering long-term adverse effects of high dose radiotherapy for early breast cancer. A secondary aim is to test mechanisms of tissue reperfusion and healing in response to HB.
Accrual began in 2006 and 63 patents are required for this trial. This is a randomised controlled trial and all interested volunteers will be referred to Professor Yarnold at the Royal Marsden Hospital, from where relevant medical information will be retrieved and eligibility criteria checked.
Chief Investigator: Professor J. Yarnold, Royal Marsden Hospital, Sutton.
Source of funding: Cancer Research UK and the Department of Health.
ISRCTN: 00743708.
In the Clinical Trials Section
